Erector Spinae Plane Block in Renal Transplantation Donors
- Conditions
- Renal TransplantationErector Spinae Plane BlockLaparoscopic Nephrectomy
- Interventions
- Procedure: Erector Spinae Plane BlockProcedure: Intravenous fentanyl patient control device
- Registration Number
- NCT04863716
- Lead Sponsor
- Koc University Hospital
- Brief Summary
Erector Spina Plan Block (ESPB) is a relatively new, easy-to-apply and safe regional anesthesia technique used to provide postoperative analgesia in various surgeries. Studies showing the clinical benefits of Erector Spina Plan block in renal transplantation surgery are limited to case reports. In this study, the effect of Erector Spina Plan Block on opioid consumption in postoperative period on donor patients who will undergo laparoscopic nephrectomy in renal transplantation surgery will be examined prospectively.
The aim of the study is to provide analgesia to donor patients using less opioids by Erector Spina Plan Block and provide enhanced recovery.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 52
- Donor patients scheduled for elective nephrectomy in renal transplantation surgery
- ASA I-II
- Patients who are aged between 18-75
- Skin infection at the Erector Spina Plan Block area
- Coagulation disorder or using anticoagulant drugs
- End-stage organ and system failure
- Severe pulmonary and/or cardiovascular problems
- Substance addiction or known psychiatric or mental problems
- Chronic painkiller usage
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Erector Spinae Plane Block Intravenous fentanyl patient control device Erector Spinae Plane Block will be administered to this group. Control Group Intravenous fentanyl patient control device No regional anesthesia technique will be applied to the control group. Erector Spinae Plane Block Erector Spinae Plane Block Erector Spinae Plane Block will be administered to this group.
- Primary Outcome Measures
Name Time Method Fentanyl consumption Postoperative 24 hours The amount of fentanyl required by the patient and given by the device will be recorded for the first 24 hours.
- Secondary Outcome Measures
Name Time Method Visual Analog Scale Postoperative 24 hours Pain of patients will be evaluated and recorded according to the Visual Analog Scale.
Modified Aldrete Score Postoperative 1 hour Modified Aldrete Score will be used in patient recovery, and scores will be recorded at 5 minute intervals.
Trial Locations
- Locations (1)
Koç University Hospital
🇹🇷Istanbul, Zeytinburnu, Turkey